Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics.
Location: United States, California, Westlake Village
Employees: 11-50
Phone: +1 818-629-2256
Total raised: $86M
Founded date: 2010
Investors 6
| Date | Name | Website |
| - | NCL Techno... | ncltv.co.u... |
| 02.11.2025 | PFM Health... | pfmhealths... |
| - | NeoMed Man... | neomed.net... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Omega Fund... | omegafunds... |
| - | Altitude L... | altitudels... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.04.2017 | Series B | $40M | ARCH Ventu... |
| 12.07.2016 | Series A | $12M | - |
| 28.04.2016 | Series A | $34M | - |
Mentions in press and media 18
| Date | Title | Description |
| 03.06.2021 | SIENNA SENIOR LIVING INC. Sienna Announces Completion of $125 Million Offering of 2.82% Series C Senior Unsecured Debentures | NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, June 03, 2021 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna”) (TSX: SIA) announced today that it has completed its previou... |
| 24.03.2021 | SIENNA SENIOR LIVING INC. Sienna Senior Living : Lincoln Park raises $4,000 for the Alzheimer Society of Niagara | 10,787 steps - one for each person living with dementia in the Niagara region. To honour the people living with dementia in their community, residents and team members at Lincoln Park Retirement Residence in Grimsby, ON, took 10,787 steps, ... |
| 24.03.2021 | Sienna Senior Living : Lincoln Park raises $4,000 for the Alzheimer Society of Niagara | 10,787 steps - one for each person living with dementia in the Niagara region. To honour the people living with dementia in their community, residents and team members at Lincoln Park Retirement Residence in Grimsby, ON, took 10,787 steps, ... |
| 27.07.2017 | Term Sheet — Thursday, July 27 | THREE THINGS Good morning, Term Sheet readers. This is Polina Marinova again, filling in for Erin. Send your feedback to polina.marinova@fortune.com, or find me on Twitter @polina_marinova. Paid Content You can't secure what you can't see F... |
| 05.07.2017 | Sienna Biopharmaceuticals Files For IPO | Westlake Village-based Sienna Biopharmaceuticals, a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. Sienna said it is hoping to raised up to $74.8M in an offering ... |
| 25.04.2017 | Sienna Biopharmaceuticals Gets $40M In Series B | Westlake Village-based Sienna Biopharmaceuticals, which is developing medical dermatology and aesthetics treatments, has raised $40M in a Series B funding. The funding was led by ARCH Venture Partners and Venvest Capital, and also included ... |
| 25.04.2017 | Sienna Biopharmaceuticals Nabs $40M | WESTLAKE VILLAGE, CA, Sienna Biopharmaceuticals today announced that it has completed a $40 million Series B financing. >> Click here for more funding data on Sienna Biopharmaceuticals >> To export Sienna Biopharmaceuticals ... |
| 25.04.2017 | Term Sheet — Tuesday, April 25 | MONEY-LOSING HOUSE OF HORRORS Contrarian: The message around Cloudera’s IPO, which is expected to price on Thursday after the market closes, has been yikes. The company was last valued at $4.1 billion; its share pricing values the company a... |
| 25.04.2017 | ARCH Venture Leads $40M Series B for Sienna Biopharmaceuticals | WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and aesthetics company, today announced that it completed a $40 million Series B financing led by existing inve... |
| 24.04.2017 | Sienna Biopharmaceuticals Announces $40 Million Series B Financing | Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and aesthetics company, today announced that it completed a $40 million Series B financing led by existing investors ARCH Venture Partners and Venvest Cap... |
Show more